PDF) WTX101 in patients newly diagnosed with Wilson disease: final
Por um escritor misterioso
Descrição
Copper homeostasis and cuproptosis in health and disease
Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study - The Lancet Gastroenterology & Hepatology
Table 4 from EASL Clinical Practice Guidelines: Wilson's disease.
PDF) Wilson's Disease: An Update on the Diagnostic Workup and Management
Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease - Paternostro - 2020 - Liver International - Wiley Online Library
Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis
PDF) Benefits and drawbacks of current copper chelators in Wilson disease
PDF) WTX101 in patients newly diagnosed with Wilson disease: final results of a global, prospective phase 2 trial
Aftab ALA, Professor, MBBS MD PhD FRCP, University of Surrey, Guildford, School of Biosciences and Medicine & Department of Health Management and Strategy
Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent
Full article: Metabolic disposition of WTX101 (bis-choline tetrathiomolybdate) in a rat model of Wilson disease
Current and Emerging Issues in Wilson's Disease
de
por adulto (o preço varia de acordo com o tamanho do grupo)
